Nasdaq: Scott+Scott Attorneys at Law LLP Files Securities Class Action Against TransMedics Group, Inc. (NASDAQ: TMDX)

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the District of Massachusetts against TransMedics Group, Inc. ("TransMedics Group" or the "Company") (NASDAQ:TMDX), and certain of its former and current officers and/or directors (collectively, "Defendants"). The Class Action asserts claims under §§10(b) and 20(a) of the Securities Exchange Act of 1934 (15 U.S.C. §§78j(b) and 78t(a)) and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b-5) on behalf of all persons other than Defendants who purchased or otherwise acquired publicly traded TransMedics securities between February 28, 2023, and January 10, 2025, inclusive (the "Class Period"), and were damaged thereby (the "Class"). The Class Action filed by Scott+Scott is captioned: Collins v. TransMedics Group, Inc., et al., Case No. 1:25-cv-10778 (D. Mass.).LEAD PLAINTIFF DEADLINE ON APRIL 15, 2025TransMedics Group operates an organ transplant ecosystem under which it offers patented technology to preserve and mobilize organs, services that support transplant centers and medical teams, and a logistics arm that facilitates the entire chain.The Class Action alleges that, during the Class Period, Defendants made misleading statements and omissions regarding the Company's business, financial condition, and prospects. Specifically, Defendants failed to disclose TransMedics used and relied upon illegal, anticompetitive, and coercive business practices, such as kickbacks, billing fraud, and overcharging patients, which caused customers to stop using TransMedics' services, made ...Full story available on Benzinga.com